V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009698 | 190004964 | 1.85 | null | null | 2020-05-30 | 2020-06-03 | ETOPOSIDE + IFOSFAMIDE + MESNA | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101702252 |
| 190009699 | 190004965 | 1.67 | 11 | Palliative (P) | 2016-03-25 | 2016-04-14 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | 02 | null | OST MIFAMURTIDE | 101276424 |
| 190009714 | 190004966 | 1.79 | null | null | 2020-09-30 | 2020-10-06 | OST Euramos 1 Closed Trial - AP | 01 | N | TRABECTEDIN | 100693857 |
| 190009718 | 190004967 | 1.71 | 100.25 | Curative (C) | 2018-04-09 | 2018-05-07 | CYCLO + DOXORUBICIN + VINCRISTINE | null | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101486306 |
| 190009726 | 190004969 | 1.2 | 36 | Palliative (P) | 2017-04-26 | 2017-05-03 | Trial Unspecified | Y | N | TRIAL UNSPECIFIED | 100301166 |
| 190009739 | 190004971 | 1.78 | 64.6 | Palliative (P) | 2018-03-09 | 2018-03-10 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | DOXORUBICIN + METHOTREXATE | 100941460 |
| 190009744 | 190004972 | 1.62 | null | Curative (C) | 2015-12-19 | 2016-05-07 | METHOTREXATE | 02 | N | METHOTREXATE | 100054242 |
| 190009746 | 190004973 | 0 | 0 | Palliative (P) | 2019-05-31 | 2019-06-14 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100319042 |
| 190009749 | 190004974 | 1.6 | 54.5 | Palliative (P) | 2018-06-21 | 2018-06-21 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101016451 |
| 190009752 | 190004975 | 1.74 | 71.7 | null | 2019-10-28 | 2019-11-01 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100133161 |
| 190009759 | 190004976 | 1.63 | 76.5 | null | 2020-01-12 | 2020-01-26 | OST Euramos 1 Closed Trial - M | 1 | null | OST M | 100644042 |
| 190009761 | 190004977 | 1.69 | 61.5 | Curative (C) | 2018-03-21 | 2018-04-06 | Carboplatin + Etoposide IV 3 day | N | N | NOT MATCHED | 100077199 |
| 190009768 | 190004978 | 1.72 | 59.7 | Palliative (P) | 2021-03-25 | 2021-03-25 | EW EuroEwing 2012 Arm B IE | 02 | Y | EW EUROEWING 2012 ARM B IE | 101135474 |
| 190009770 | 190004979 | 1.67 | 65 | Palliative (P) | 2017-03-18 | 2017-11-12 | EW EuroEwing 2012 Arm B IE | null | null | EW EUROEWING 2012 ARM B IE | 101800305 |
| 190009775 | 190004981 | 1.54 | 95.9 | Palliative (P) | 2017-07-19 | 2017-07-19 | Cisplatin + Etoposide (3 day) | 02 | N | EW EUROEWING 2012 ARM A VAI | 100848071 |
| 190009779 | 190004982 | null | 93.4 | null | 2021-02-07 | 2021-02-19 | PAM x 2 post-surgery (cycles 3&4) | N | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100310566 |
| 190009780 | 190004983 | null | 22.5 | Neo-adjuvant (N) | 2018-06-02 | 2018-06-02 | ECX | 1 | N | IFOSFAMIDE | 100020687 |
| 190009784 | 190004984 | 1.72 | 33.5 | Curative (C) | 2016-03-02 | 2016-08-20 | VAC | 02 | N | EURAMOS TRIAL | 100891391 |
| 190009788 | 190004985 | 1.6 | 79 | Palliative (P) | 2019-05-01 | 2019-05-19 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100428625 |
| 190009789 | 190004986 | 1.87 | 56.1 | null | 2019-12-01 | 2019-12-22 | OST Euramos 1 Closed Trial - A | 02 | Y | OST A | 100968835 |
| 190009801 | 190004987 | 1.78 | 90 | Curative (C) | 2021-04-11 | 2021-04-13 | EW EuroEwing 2012 Arm B IE | N | N | EW EUROEWING 2012 ARM B IE | 101205250 |
| 190009805 | 190004988 | 1.67 | 100 | Neo-adjuvant (N) | 2019-04-27 | 2019-05-10 | null | 02 | N | OST MIFAMURTIDE | 100410947 |
| 190009811 | 190004989 | 1.82 | 63.5 | null | 2017-11-17 | 2017-12-09 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100797259 |
| 190009815 | 190004990 | 1.72 | 94.4 | Neo-adjuvant (N) | null | 2019-12-05 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101573241 |
| 190009817 | 190004991 | 1.81 | 93 | Curative (C) | 2017-01-09 | 2017-01-09 | OST Euramos 1 Closed Trial - AP | 02 | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101624875 |
| 190009824 | 190004992 | 1.79 | 54 | null | 2018-04-12 | 2018-04-14 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101041721 |
| 190009831 | 190004993 | 1.8 | 50 | null | 2018-06-28 | 2018-07-16 | DOCETAXEL + GEMCITABINE | 02 | Y | DOCETAXEL + GEMCITABINE | 101813836 |
| 190009834 | 190004994 | 1.78 | 69 | Palliative (P) | 2018-08-12 | 2018-10-24 | CAPECITABINE + OXALIPLATIN | 01 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101779417 |
| 190009837 | 190004995 | 0 | 28.8 | Palliative (P) | 2020-01-22 | 2020-01-22 | CYTARABINE + FLUDARABINE | 02 | N | ETOPOSIDE | 100661297 |
| 190009840 | 190004996 | 1.53 | 81.25 | Palliative (P) | 2018-07-11 | 2018-07-12 | CISPLATIN + FLUOROURACIL | 02 | null | IFOSFAMIDE | 100295606 |
| 190009841 | 190004997 | 1.4 | 107 | null | 2016-06-07 | 2016-11-24 | LANREOTIDE | 02 | N | EURO-EWING | 100215774 |
| 190009842 | 190004998 | 1.61 | 105.2 | Palliative (P) | 2017-06-09 | 2017-06-09 | Oxaliplatin + Modified de Gramont | 02 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100070652 |
| 190009843 | 190004999 | 1.91 | 57.75 | Curative (C) | null | 2017-06-21 | DOXORUBICIN | null | null | DOXORUBICIN | 101154844 |
| 190009854 | 190005000 | null | 88.25 | Palliative (P) | 2016-05-20 | 2016-10-03 | EW EuroEwing 2012 Arm B IE | N | Y | EW EUROEWING 2012 ARM B IE | 100000105 |
| 190009856 | 190005001 | 1.83 | null | null | 2020-09-29 | 2020-10-24 | EW EuroEwing 2012 Arm B IE | 02 | N | EW EUROEWING 2012 ARM B IE | 100197413 |
| 190009857 | 190005002 | 1.56 | 55 | null | 2015-07-08 | 2016-01-17 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100491230 |
| 190009865 | 190005003 | 1.58 | 38.2 | Adjuvant (A) | null | 2016-11-01 | Docetaxel 100mg/m2 (21 day) | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100326896 |
| 190009873 | 190005004 | 1.56 | 99.2 | null | null | 2018-07-20 | Methotrexate Intermed dose (1g/m2) | N | N | METHOTREXATE | 100717419 |
| 190009878 | 190005005 | 0 | 60.8 | Curative (C) | null | 2019-04-25 | null | null | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100482626 |
| 190009881 | 190005006 | 1.63 | 72.5 | Palliative (P) | null | 2019-10-28 | OST Mifamurtide | 02 | Y | EW EUROEWING 2012 ARM A VAI | 101302257 |
| 190009882 | 190005007 | 1.57 | 89.7 | Curative (C) | 2018-03-04 | 2018-09-14 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101714439 |
| 190009884 | 190005008 | 1.66 | 33.5 | null | 2018-09-07 | 2018-09-07 | Methotrexate High Dose (3g/m2) | 01 | N | METHOTREXATE | 101798406 |
| 190009897 | 190005009 | null | 91.8 | Neo-adjuvant (N) | 2019-10-07 | 2019-10-13 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101513878 |
| 190009898 | 190005010 | 1.64 | 58.7 | Palliative (P) | 2019-04-30 | 2019-10-12 | Doxorubicin + Methotrexate | 02 | N | DOXORUBICIN + METHOTREXATE | 101867610 |
| 190009905 | 190005012 | 0 | 54.7 | Palliative (P) | null | 2019-07-27 | Paclitaxel albumin (Abraxane) 21day | 02 | null | METHOTREXATE HIGH DOSE | 100935290 |
| 190009910 | 190005013 | 1.74 | 82.85 | null | 2016-02-20 | 2016-04-03 | Methotrexate Intermed dose (1g/m2) | 02 | N | METHOTREXATE | 101791109 |
| 190009914 | 190005014 | 1.7 | null | null | 2018-03-18 | 2018-08-23 | STS NON-RHABDO EPSSG 2005 VDC/IE | N | null | ETOPOSIDE | 101292391 |
| 190009917 | 190005015 | 1.75 | 57.5 | 03 | 2020-11-17 | 2021-08-14 | OST Euramos 1 Closed Trial - M | 01 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100316004 |
| 190009928 | 190005016 | 1.55 | 62.6 | Palliative (P) | 2020-03-12 | 2020-03-13 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101608054 |
| 190009929 | 190005017 | 1.69 | 55 | Curative (C) | null | 2016-05-08 | CTD (Thalidomide 100mg) | 02 | null | EW EUROEWING 2012 ARM B VDC | 100958520 |